Test Price
2,800 AED✅ Home Collection Available
SPART (SPG20) Gene Genetic Test in Dubai Healthcare City | 2800 AED | DHA Licensed Lab #1143
Executive Summary & Core Metrics
✅ Accuracy Guarantee:
99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
🏥 Premium Logistics:
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, available daily from 8 AM to 11 PM.
📋 Clinical Guidance:
Telephonic Post-Test Clinical Guidance by certified genetic counsellors and neurologists to interpret your results.
💳 Insurance Assistance:
Direct Billing Verification via WhatsApp +971 54 548 8731 – we handle all UAE insurance networks.
Test Overview & Methodology
The SPART (SPG20) gene NGS test detects pathogenic variants linked to hereditary spastic paraplegia (Troyer syndrome) with near‑complete gene coverage. This single‑test approach replaces sequential Sanger sequencing, reducing turnaround time and increasing diagnostic yield.
| Feature | Our SPART NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full gene with exon/intron boundaries | Sanger sequencing of coding regions only (limited coverage) |
| Diagnostic Sensitivity | 99.9% for SNVs, indels, and CNVs | ~95%, may miss deep intronic or copy‑number changes |
| Turnaround Time | 3 – 4 Weeks | 4 – 6 Weeks (fragmented reflex testing) |
| Price | 2800 AED | ~3200 AED (incremental costs) |
| Clinical Reporting | ICD‑10 & LOINC‑coded, DHA‑compliant report | Generic molecular report |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics specialist, I recognize the emotional weight that accompanies genetic testing for hereditary conditions. This SPG20 test offers a definitive molecular diagnosis, but it must be correlated with your clinical history by a specialist. Please consult with a genetic counselor or your referring neurologist before and after testing to fully understand the results and their implications for you and your family.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
⛔ Medication Advisory Notice
Do not discontinue prescribed medication without consulting your doctor.
Some antispasmodic or neurological drugs may influence clinical presentation; abrupt withdrawal can be dangerous. This test does not replace ongoing therapy.
🚨 Exclusion Criteria & Emergency Red Flags
- Exclusion: Inability to provide informed consent (except with legal guardian), active acute infection or autoimmune flare interfering with sample integrity, incomplete clinical history.
- ER Red Flags: Seek immediate medical attention if you develop sudden severe muscle weakness, loss of bladder/bowel control, difficulty breathing, or chest pain. This genetic test is not an emergency diagnostic tool.
- Genetic testing of minors is conducted strictly in accordance with UAE Federal Decree-Law No. 4 of 2016 on Medical Liability; parental consent and a court order may be required.
Patient FAQ & Clinical Guidance
1. What is the SPART (SPG20) gene test and why is it performed?
The SPART (SPG20) gene NGS test is a comprehensive DNA sequencing analysis that detects mutations in the SPG20 gene responsible for Troyer syndrome, a form of hereditary spastic paraplegia. It is ordered by neurologists or geneticists when a patient presents with progressive lower limb spasticity, muscle wasting, or a positive family history, to confirm the diagnosis and guide management.
2. How should I prepare for the test and what sample types are accepted?
The test requires a simple blood draw collected in a special DNA-preserving tube, or a dried blood spot on an FTA card; no fasting or medication adjustments are needed unless directed by your physician. Our home collection team will handle the cold-chain logistics, and your genetic counselling session will be scheduled prior to sample submission.
3. What is the turnaround time and how will I receive my results?
Results are delivered in a secure, DHA‑compliant report within 3 to 4 weeks, complete with ICD‑10 and LOINC coding; a telephonic counselling session is offered to explain the findings in plain language. Your named genetic counsellor will guide you through the pathogenic or benign interpretation and discuss next steps.
UAE Regulatory & Data Privacy Adherence
- Data Protection: Complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical Safety: Adheres to Federal Decree-Law No. 4 of 2016 on Medical Liability for patient consent and clinical testing safety.
- Accreditation: ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
- DHA License: Facility License Number 1143, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | SPART (SPG20) Gene NGS Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 weeks |
| Sample Type / Matrix | Whole blood (EDTA), dried blood spot (FTA card), or extracted DNA |
| Methodology Used | Next‑Generation Sequencing (NGS) – whole gene coding & non‑coding regions |
| ICD-10-CM Code | G11.4 (Hereditary spastic paraplegia) |
| LOINC Code | 48817-2 (SPG20 gene mutation analysis) |
| DHA Facility License & Address | License #1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians